견관절 성형술 시장 보고서 : 디바이스, 시술, 적응증, 최종사용자, 지역별(2025-2033년)

The global shoulder arthroplasty market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is propelled by the increasing incidence of shoulder arthritis, development of better implant materials, expanding indications for shoulder replacement procedures, rising population of geriatrics, and heightened consciousness of invasive surgeries.

Shoulder arthroplasty is a surgical procedure wherein diseases or damaged ball and socket joints of the shoulder are replaced with a prosthesis made of metal components or plastic implants. It is generally performed after a thorough evaluation of patients using x-rays, blood tests, bone scans, physical examinations, computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans. Presently, it is used to treat individuals with primary osteoarthritis, post-traumatic arthritis, inflammatory arthritis, proximal humeral fractures, osteonecrosis of the humeral head and neck, and pseudo paresis caused by rotator cuff deficiency.

Shoulder Arthroplasty Market Trends:

Several conditions, such as inflammatory arthritis, osteonecrosis involving the glenoid and post-traumatic degenerative joint disease, can cause shoulder pain and disability and interfere with the everyday activities of patients. Thus, a significant rise in the number of individuals suffering from these conditions represents one of the key factors augmenting the need for shoulder arthroplasty. Moreover, as shoulder pain increases with age, the growing aging population is catalyzing the adoption of shoulder arthroplasty to preserve their shoulder joint mobility and function. Apart from this, high-force and repetition activities required by athletics during performance can result in severe shoulder fracture or damage. This, in confluence with the increasing participation of individuals in professional sports, is influencing the market positively. Furthermore, market players are offering an extensive array of implants for shoulder reconstruction in different conditions. They are also introducing modern implants with a wide range of options, including resurfacing the humeral head, anatomic hemiarthroplasty, total shoulder arthroplasty, reverse shoulder arthroplasty, and trauma-specific implants for fractures and nonunions. This is anticipated to expand their overall share and drive the market in the coming years.

Key Market Segmentation:

Breakup by Device:

• Shoulder Arthroplasty Resurfacing Implants
• Shoulder Arthroplasty Trauma Devices
• Shoulder Arthroplasty Platform Systems

Breakup by Procedure:

• Partial Shoulder Arthroplasty
• Total Shoulder Arthroplasty
• Revision Shoulder Arthroplasty

Breakup by Indication:

• Arthritis
• Fracture/Dislocation
• Rotator Cuff Tear Arthropathy
• Hill Sachs Defect
• Others

Breakup by End User:

• Hospitals
• Orthopedic Centers
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., BioTek Instruments Inc. (Agilent Technologies Inc.), Conmed Corporation, DJO Global (Colfax Corporation), Exactech Inc., Implantcast GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Kinamed Incorporated, Limacorporate S.p.A., Medacta Group, Smith and Nephew Plc, Stryker Corporation and Zimmer Biomet.

Key Questions Answered in This Report

• 1.What was the size of the global shoulder arthroplasty market in 2024?
• 2.What is the expected growth rate of the global shoulder arthroplasty market during 2025-2033?
• 3.What are the key factors driving the global shoulder arthroplasty market?
• 4.What has been the impact of COVID-19 on the global shoulder arthroplasty market?
• 5.What is the breakup of the global shoulder arthroplasty market based on the procedure?
• 6.What is the breakup of the global shoulder arthroplasty market based on the end user?
• 7.What are the key regions in the global shoulder arthroplasty market?
• 8.Who are the key players/companies in the global shoulder arthroplasty market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Shoulder Arthroplasty Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Device

• 6.1 Shoulder Arthroplasty Resurfacing Implants
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Shoulder Arthroplasty Trauma Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Shoulder Arthroplasty Platform Systems
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Procedure

• 7.1 Partial Shoulder Arthroplasty
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Total Shoulder Arthroplasty
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Revision Shoulder Arthroplasty
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Indication

• 8.1 Arthritis
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Fracture/Dislocation
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Rotator Cuff Tear Arthropathy
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Hill Sachs Defect
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Orthopedic Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Ambulatory Surgical Centers
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Arthrex Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 SWOT Analysis
  • 15.3.2 BioTek Instruments Inc. (Agilent Technologies Inc.)
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Conmed Corporation
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 DJO Global (Colfax Corporation)
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Exactech Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Implantcast GmbH
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Integra LifeSciences Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Johnson & Johnson
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Kinamed Incorporated
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Limacorporate S.p.A.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Medacta Group
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
  • 15.3.12 Smith and Nephew Plc
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis
  • 15.3.13 Stryker Corporation
    • 15.3.13.1 Company Overview
    • 15.3.13.2 Product Portfolio
    • 15.3.13.3 Financials
    • 15.3.13.4 SWOT Analysis
  • 15.3.14 Zimmer Biomet
    • 15.3.14.1 Company Overview
    • 15.3.14.2 Product Portfolio
    • 15.3.14.3 Financials
    • 15.3.14.4 SWOT Analysis